Mammaplasty
36
6
7
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
2 terminated out of 36 trials
91.3%
+4.8% vs benchmark
14%
5 trials in Phase 3/4
14%
3 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (36)
Electrical Stimulation for Improving Postoperative Breast Sensation
Motiva Flora® Aesthetic Breast Recon® Clinical Study
NPWT Reduction Mammaplasty
The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
NovoX®Cup as Primary Dressing After Breast Reduction
Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty
Comparison of ESP and SPSIP Blocks in Breast Surgery
Diced Cartilage in Breast Reconstruction
ARTISS a Single-centre Randomised Control Study
Safety and Performance of Motiva® Sizers
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
Accuracy of Deep Inferior Epigastric Artery Perforator Mapping - Color Doppler Ultrasound Versus CT Angiography
Breast Reconstruction With Autologous Tissue: Microsurgery or Fat Grafting?
Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander
Breast Reconstruction in Previously Irradiated Breast
Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction
Satisfaction and QUality of Life After Breast REconstruction